Evaluation of Middle Ear Implantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00451503|
Recruitment Status : Completed
First Posted : March 23, 2007
Last Update Posted : July 10, 2012
|Condition or disease||Intervention/treatment|
|Hearing Loss||Device: Middle Ear Implant|
Objective: The main objective of this study is to demonstrate that the middle ear implant increases the hearing in terms of speech intelligibility in quiet and noisy conditions, in patients who have no further benefit of their conventional hearing aid. The quality of life of these patients will be evaluated as well as the tolerance of the middle ear implant after 6 months.
Design of the study: 420 patients with mid or severe hearing loss will be included. They will have for 3 months the best conventional hearing aid adapted to their hearing loss. The first 84 patients who will not have a benefit of this hearing aid, will be randomised in two groups. The patients of the first group will be operated as soon as possible, the surgery of the patients of the second group will be delayed by 6 months. The whole duration of the study is 48 months.
Evaluation criteria: Audiological testing (pure-tone hearing thresholds, speech comprehension in quiet and noise), and subjective evaluation using self-assessment scales will be performed before and 6 months after the implantation in the two groups.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||69 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of Middle Ear Implants in the Therapeutic Strategy of Auditory Rehabilitation in Case of Failure of Conventional Hearing Aid|
|Study Start Date :||March 2007|
|Primary Completion Date :||January 2011|
|Study Completion Date :||June 2012|
Device: Middle Ear Implant
Other Name: surgery
- Assessment of the middle ear implant on speech intelligibility in quiet and noise in case of failure of conventional hearing aid [ Time Frame: during the study ]
- Assessment of the life quality of patients [ Time Frame: during the study ]
- Assessment of the tolerance at 6 months postoperative of the middle ear [ Time Frame: 6 months postoperative ]
- implantation [ Time Frame: during the study ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00451503
|Clichy, France, 92110|
|Principal Investigator:||Olivier STERKERS, MD,PhD||Assistance Publique - Hôpitaux de Paris|